Cadrien, Cornelius
Sharma, Sukrit
Lazen, Philipp
Licandro, Roxane
Furtner, Julia
Lipka, Alexandra
Niess, Eva
Hingerl, Lukas
Motyka, Stanislav
Gruber, Stephan
Strasser, Bernhard
Kiesel, Barbara
Mischkulnig, Mario
Preusser, Matthias
Roetzer-Pejrimovsky, Thomas
Wöhrer, Adelheid
Weber, Michael
Dorfer, Christian
Trattnig, Siegfried
Rössler, Karl
Bogner, Wolfgang
Widhalm, Georg
Hangel, Gilbert https://orcid.org/0000-0002-3986-3159
Funding for this research was provided by:
Austrian Science Fund (projects KLI 646, KLI 1089, KLI 679)
Christian Doppler Forschungsgesellschaft
Comprehensive Cancer Center
Article History
Received: 13 September 2023
Accepted: 27 April 2024
First Online: 27 May 2024
Declarations
:
: Institutional Review Board (IBR) approval was obtained by the IBR of the Medical University of Vienna, protocol 1991/2018. Written informed consent was obtained from all subjects (patients) in this study.
: All subjects consented to a publication of their pseudonymized or anonymized data.
: Julia Furtner has received honoraria for lectures and consultation from the following for-profit companies: Novartis; Seagen.Matthias Preusser has received honoraria for lectures, consultation or advisory board participation from the following for-profit companies: Bayer; Bristol-Myers Squibb; Novartis; Gerson Lehrman Group (GLG); CMC Contrast; GlaxoSmithKline; Mundipharma; Roche; BMJ Journals; MedMedia; Astra Zeneca; AbbVie; Lilly; Medahead; Daiichi Sankyo; Sanofi; Merck Sharp & Dohme; Tocagen; Adastra; Gan & Lee Pharmaceuticals; Servier.The other authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.